| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/17/2006 | EP1656346A1 Novel substituted 3-sulfur indoles |
| 05/17/2006 | EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656132A2 Novel pyrrole-based hmg-coa reductase inhibitors |
| 05/17/2006 | EP1656096A2 Methods of reducing risk of infection from pathogens |
| 05/17/2006 | EP1656020A2 Pyridinylanilides |
| 05/17/2006 | EP1551821B1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774425A Quinazoline compounds |
| 05/17/2006 | CN1774421A Process for preparing 5-(4- fluorophenyl)- 1-[2r, 4r) -4-hydroxy-6-oxo- tetrahydro-pyran -2-yl) ethyl]-2 -isopropyl -4-phenyl- 1h-pyrrole-3 -carboxylic acid phenylamide |
| 05/17/2006 | CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 05/17/2006 | CN1774245A Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 05/17/2006 | CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 05/17/2006 | CN1256329C Herbicidal substituted benzoylpyrazoles |
| 05/17/2006 | CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/16/2006 | US7045629 Method for producing-2[-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane |
| 05/16/2006 | US7045626 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23 |
| 05/16/2006 | US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 05/16/2006 | US7045544 Myocardium; angina pectoris |
| 05/16/2006 | US7045532 ACE-2 modulating compounds and methods of use thereof |
| 05/16/2006 | US7045527 Piperidine derivatives |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | US7045519 Pyrimidine or pyridine derivatives |
| 05/16/2006 | US7045517 Triazine compounds |
| 05/16/2006 | US7045515 Anticholesterol agents |
| 05/16/2006 | US7045514 Therapeutic heterocyclic compounds |
| 05/16/2006 | CA2244903C Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 05/16/2006 | CA2227386C Piperazine derivatives and their use as 5-ht1a antagonists |
| 05/16/2006 | CA2192916C Substituted chromanylsulfonyl(thio)ureas, processes for their preparation, their use in pharmaceutical preparations, and pharmaceutical preparations comprising them |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006049297A1 Novel nucleoside or nucleotide derivative and use thereof |
| 05/11/2006 | WO2006048761A2 Methods for preparing indazole compounds |
| 05/11/2006 | WO2006048745A1 Methods for preparing indazole compounds |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2005103039A8 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists |
| 05/11/2006 | WO2005072082B1 2-guanidinylimidazolidinedione compounds and methods of making and using thereof |
| 05/11/2006 | US20060100446 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100445 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100267 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100259 Process for the preparation of substituted triazole compounds |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100248 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100245 Substituted biphenyl-4-carboxylic acid arylamide analogues |
| 05/11/2006 | US20060100242 4-(2-Phenylsulfanyl-phenyl)-piperidine derivates as serotonin reuptake inhibitors |
| 05/11/2006 | US20060100230 Indolin phenylsulfonamide derivatives |
| 05/11/2006 | US20060100225 Heteroaryl guanidines; inhibitors of viral replication |
| 05/11/2006 | US20060100224 Piperidine ouracil used as a medicament for treating bacterial infections |
| 05/11/2006 | US20060100223 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/11/2006 | US20060100218 Phosphodiesterase 4; asthma, chronic obstructive pulmonary disease, Alzheimer's disease, diffuse large-cell B cell lymphoma, and chronic lymphocytic leukemia; 8-[3-(3,4-dimethoxy-phenyl)-pyrrolo[2,3-b]pyridine-1-sulfonyl]-quinoline |
| 05/11/2006 | US20060100216 Novel B1 bradykinin receptor antagonists |
| 05/11/2006 | US20060100213 Triazoles and methods of use |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100207 Dihydropyridinone derivatives |
| 05/11/2006 | US20060100201 5-Cyano-furan-2-carboxylic acid (4-morpholin-4-yl-2-piperidin-1-yl-phenyl)-amide; selective and potent protein tyrosine kinase inhibitors providing inhibition of c-fms kinase; treating autoimmune diseases and diseases with an inflammatory component; treating metastasis from ovarian, breast cancer |
| 05/11/2006 | US20060100192 Heteroaryl diazacycloalkanes, their preparation and use |
| 05/11/2006 | US20060100191 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide, and a carrier; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator |
| 05/11/2006 | CA2591313A1 Methods for preparing indazole compounds |
| 05/11/2006 | CA2589106A1 Pyridazine compounds, compositions and methods and their use in treating inflammatory diseases |
| 05/11/2006 | CA2586176A1 Methods for preparing indazole compounds |
| 05/11/2006 | CA2585535A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/10/2006 | EP1655294A2 Chromene compound |
| 05/10/2006 | EP1655293A2 Chromene compound |
| 05/10/2006 | EP1655037A1 Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 05/10/2006 | EP1654251A1 Chemical compounds |
| 05/10/2006 | EP1654247A1 Alkynyl aryl carboxamides |
| 05/10/2006 | EP1654244A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |
| 05/10/2006 | EP1654238A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 05/10/2006 | EP1653976A1 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653961A1 Inhibitors of akt activity |
| 05/10/2006 | EP1653960A2 Melanin concentrating hormone receptor antagonist |
| 05/10/2006 | EP1653944A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/10/2006 | EP1536799B1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771249A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771248A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771237A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1770980A Pyrazoles and methods of making and using the same |
| 05/10/2006 | CN1769285A Doxazosin salt with optical activity |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769274A Pyrazinone protease inhibitors |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255396C Carboxylic acid derivatives having fused rings |
| 05/10/2006 | CN1255382C Modulators of dopamine neurotransmission |
| 05/10/2006 | CN1255380C Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/09/2006 | US7041837 Heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/09/2006 | US7041821 substituted 3-hydroxy-6-oxo-9-phenyl anthracene, acridine, xanthene, or thioxanthene zinc chelating compounds; fluorescent labels for recombinant fusion proteins; nontoxic alternative to nickel based labeling systems; nonreducing environments, cell surfaces |